BRCA2 and ovarian cancer: To further investigate the role of RAD51C as an HBOC predisposition gene, we performed complete sequencing of RAD51C to screen for mutations in 286 BRCA1- and BRCA2-negative breast and/or ovarian cancer cases with a family history of breast and ovarian cancer.